Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.
2010Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjectsMa, J.; Chang, J.; Checklin, H.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2013A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetesMa, J.; Checklin, H.; Wishart, J.; Stevens, J.; Jones, K.; Horowitz, M.; Meyer, J.; Rayner, C.
2012Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humansWu, T.; Zhao, R.; Bound, M.; Checklin, H.; Bellon, M.; Little, T.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2016Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2014Changes in meal composition and duration affect postprandial endothelial function in healthy humansThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Jones, K.; Willoughby, S.; Horowitz, M.; Rayner, C.
2014Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetesMarathe, C.; Rayner, C.; Bound, M.; Checklin, H.; Standfield, S.; Wishart, J.; Lange, K.; Jones, K.; Horowitz, M.
2016Effect of duodenal glucose load on blood pressure in type 2 diabetesMarathe, C.; Horowitz, M.; Trahair, L.; Bound, M.; Checklin, H.; Lange, K.; Rayner, C.; Jones, K.
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.